HomeC17 • FRA
add
Corvus Pharmaceuticals Inc
Previous close
€3.40
Day range
€3.48 - €3.48
Year range
€1.59 - €9.00
Market cap
299.98M USD
Avg Volume
2.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.92M | 58.68% |
Net income | 15.19M | 366.50% |
Net profit margin | — | — |
Earnings per share | -0.14 | -14.83% |
EBITDA | -9.90M | -58.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.21M | 99.80% |
Total assets | 59.44M | 48.28% |
Total liabilities | 10.11M | 50.49% |
Total equity | 49.32M | — |
Shares outstanding | 77.11M | — |
Price to book | 4.72 | — |
Return on assets | -38.65% | — |
Return on capital | -58.94% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 15.19M | 366.50% |
Cash from operations | -8.26M | -60.23% |
Cash from investing | 4.24M | 60,714.29% |
Cash from financing | 279.00K | — |
Net change in cash | -3.74M | 27.56% |
Free cash flow | -30.06M | -926.85% |
About
Founded
2014
Headquarters
Website
Employees
31
